Perrigo (NYSE:PRGO) issued an update on its FY18 earnings guidance on Thursday morning. The company provided EPS guidance of $4.45-4.65 for the period, compared to the Thomson Reuters consensus EPS estimate of $4.86. The company issued revenue guidance of ~$4.72 billion, compared to the consensus revenue estimate of $4.87 billion.Perrigo also updated its FY 2018 guidance to $4.45-4.65 EPS.
Shares of Perrigo stock traded up $0.32 during midday trading on Friday, reaching $63.20. The company had a trading volume of 91,839 shares, compared to its average volume of 1,289,519. The company has a debt-to-equity ratio of 0.52, a current ratio of 1.81 and a quick ratio of 1.23. The firm has a market cap of $10.11 billion, a P/E ratio of 12.81, a P/E/G ratio of 2.39 and a beta of 0.66. Perrigo has a fifty-two week low of $62.86 and a fifty-two week high of $95.93.
Perrigo (NYSE:PRGO) last posted its quarterly earnings data on Thursday, November 8th. The company reported $1.09 EPS for the quarter, topping the Zacks’ consensus estimate of $1.05 by $0.04. The company had revenue of $1.13 billion for the quarter, compared to analyst estimates of $1.17 billion. Perrigo had a return on equity of 11.92% and a net margin of 4.77%. The firm’s quarterly revenue was down 8.0% on a year-over-year basis. During the same period in the previous year, the firm earned $1.39 earnings per share. Equities analysts anticipate that Perrigo will post 4.85 earnings per share for the current fiscal year.
PRGO has been the topic of a number of recent analyst reports. Cantor Fitzgerald reaffirmed a buy rating and issued a $107.00 price objective on shares of Perrigo in a research note on Wednesday, July 18th. Royal Bank of Canada set a $63.00 price objective on Perrigo and gave the stock a hold rating in a research note on Friday. ValuEngine lowered Perrigo from a sell rating to a strong sell rating in a research note on Friday, September 14th. Deutsche Bank lowered Perrigo from a buy rating to a hold rating and cut their price objective for the stock from $93.00 to $78.00 in a research note on Friday, August 10th. Finally, Canaccord Genuity set a $90.00 price objective on Perrigo and gave the stock a buy rating in a research note on Friday, August 17th. Two analysts have rated the stock with a sell rating, ten have issued a hold rating and four have given a buy rating to the stock. The company has a consensus rating of Hold and an average target price of $87.80.
In other Perrigo news, EVP Svend Andersen purchased 7,200 shares of the company’s stock in a transaction on Tuesday, August 14th. The shares were purchased at an average cost of $69.43 per share, with a total value of $499,896.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. 6.90% of the stock is currently owned by insiders.
TRADEMARK VIOLATION NOTICE: This article was originally posted by Sports Perspectives and is the property of of Sports Perspectives. If you are reading this article on another domain, it was stolen and republished in violation of United States and international copyright and trademark law. The original version of this article can be read at https://sportsperspectives.com/2018/11/09/perrigo-prgo-issues-fy18-earnings-guidance.html.
Perrigo Company plc, a healthcare company, manufactures and supplies over-the-counter (OTC) healthcare products, infant formulas, branded OTC products, and generic pharmaceutical products worldwide. The company operates through Consumer Healthcare Americas, Consumer Healthcare International, and Prescription Pharmaceuticals segments.
Featured Article: What is a put option?
Receive News & Ratings for Perrigo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Perrigo and related companies with MarketBeat.com's FREE daily email newsletter.